FNYS
MACK

First New York Securities’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

First New York Securities’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-477
Closed -$23.8K – 241
2016
Q3 		$23.8K Buy
+477
New +$23.8K 0.02% 150
2014
Q4 		– Sell
-318
Closed -$22K – 551
2014
Q3 		$22K Buy
+318
New +$22K 0.02% 320